4.7 Review

Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

Guanghui Zheng et al.

Summary: The study aimed to investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival. Results showed that MCC950 improved post-resuscitation myocardial function and microcirculation, reduced inflammatory response, and increased survival and neurologic deficit scores.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

Review Cardiac & Cardiovascular Systems

Mitochondrial permeability transition pore-dependent necrosis

Dexter J. Robichaux et al.

Summary: Mitochondrial permeability transition pore (mPTP)-dependent cell death is a form of necrotic cell death that is driven by mitochondrial dysfunction and is triggered by increases in matrix levels of Ca2+ and reactive oxygen species. It has been implicated in ischemic injuries of the heart and brain as well as numerous degenerative diseases in the brain and skeletal muscle. This review focuses on the molecular triggers and regulators of mPTP-dependent necrosis in the context of myocardial ischemia reperfusion injury.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2023)

Review Pharmacology & Pharmacy

Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction

Qiang Ma

Summary: The NLRP3 inflammasome is a multiprotein complex involved in regulating inflammation in health and disease. It is activated by inflammation-inducing signals and plays a key role in the pathogenesis of various diseases. Pharmacological targeting of NLRP3 has shown promising results in the treatment of these diseases.

PHARMACOLOGICAL REVIEWS (2023)

Review Immunology

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Xiaoyan Zhan et al.

Summary: NLRP3 is a cytosolic pattern recognition receptor that recognizes various molecular patterns associated with pathogens and damage. Its activation leads to the assembly of the inflammasome and cleavage of IL-1 beta and IL-18. Aberrant NLRP3 activation is linked with multiple inflammatory diseases, and efforts are being made to develop inhibitors. This review summarizes the latest advances in the mechanism of NLRP3 inflammasome activation and the development of pharmacological inhibitors.

FRONTIERS IN IMMUNOLOGY (2023)

Review Multidisciplinary Sciences

Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review

Cuihua Liu et al.

Summary: Reperfusion therapy is commonly used to treat ischemic cardiomyopathy, but it can lead to myocardial ischemia reperfusion injury (MIRI), affecting patient outcomes. This review analyzed the relationship between ferroptosis and mitophagy in MIRI, and discussed the role of mTOR, NLPR3 and HIF. Simultaneous regulation of mitophagy and ferroptosis may be more effective for MIRI treatment. Potential drugs that can modulate mitophagy and/or ferroptosis were summarized, providing reference for the development of MIRI treatments.
Article Chemistry, Medicinal

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation

Simone Gastaldi et al.

Summary: Inspired by recent advancements, new NLRP3 inhibitors were developed and showed promising results in maintaining interaction with the target protein. One of the compounds, INF200, demonstrated significant inhibition of NLRP3-dependent pyroptosis and IL-1 beta release in human macrophages. In an in vivo rat model, INF200 effectively improved cardiometabolic dysfunction associated with obesity, reducing anthropometric changes, improving glucose and lipid profiles, and attenuating systemic inflammation and cardiac dysfunction.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Pharmacology & Pharmacy

Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning

Claudia Penna et al.

Summary: Since the introduction of coronary reperfusion in the late 1970s, the translation of successful animal experiments on cardioprotection into clinical practice has been disappointing. Animal experiments are often lacking the risk factors, co-morbidities and co-medications characteristic of acute myocardial infarction patients. The long-term effects of additional cardioprotection, particularly regarding vessel protection, repair, inflammation, remodeling, and mortality, are not well-studied. Species differences, co-morbidities, vascular damage, inflammatory processes, and co-medications often limit the reproducibility and robustness of experimental studies. Future studies should focus on interventions with reliable preclinical data and recruit patients who have the potential to benefit from further cardioprotection.

VASCULAR PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review

JingWen Yong et al.

Summary: This review examines the use of colchicine as an effective anti-inflammatory agent and its impact on ischemic events and mortality reduction. The study suggests that low-dose colchicine has the potential to become a new standard therapy for the prevention of coronary artery disease-related atherothrombotic events.

CLINICAL THERAPEUTICS (2022)

Article Pharmacology & Pharmacy

Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome

Hao Li et al.

Summary: NOD-like receptor protein 3 (NLRP3) is an important intracellular pattern recognition receptor associated with several human diseases. MCC950, a specific small-molecule inhibitor, blocks activation of the NLRP3 inflammasome. Preclinical and clinical studies have shown promising results for the clinical therapeutic potential of MCC950.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Medicine, General & Internal

Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease

Anna Kablak-Ziembicka et al.

Summary: MicroRNAs (miRs) play important roles in the diagnosis, prognosis and treatment of atherosclerotic cardiovascular disease, a globally significant condition affecting a wide range of clinical cases. Studying the expression of miRs in CAD and ACS can provide clinicians with vital information.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Pharmacology & Pharmacy

Targeting the NLRP3 inflammasome in cardiovascular diseases

Stefano Toldo et al.

Summary: The NLRP3 inflammasome plays a crucial role in cardiovascular diseases and targeting this protein complex has shown promising therapeutic effects. IL-1 blockade and colchicine are current treatment options.

PHARMACOLOGY & THERAPEUTICS (2022)

Review Cardiac & Cardiovascular Systems

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases

Jiahao Zhao et al.

Summary: ROS metabolism is crucial for cellular homeostasis. Excessive production of ROS can damage cells, while appropriate levels of ROS serve as important signaling molecules. MAMs play various roles in the progression of cardiovascular disease, with their ability to mediate ROS generation being the most significant.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Immunology

RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis

Shireen Mohammad et al.

Summary: This study described the characteristics and effects of a novel small molecule AQP9 inhibitor, RG100204, in a polymicrobial infection model. The results showed that RG100204 could attenuate the cardiac and renal dysfunction caused by sepsis, indicating that AQP9 may be a potential drug target for polymicrobial sepsis.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Multi-faceted roles of cathepsins in ischemia reperfusion injury (Review)

Jaime Huertas et al.

Summary: This review summarizes the diverse physiological effects of cathepsins, including immune responses, cell death, and intracellular protein degradation. Cathepsins play a crucial role in ischemia reperfusion injury, and modulation of cathepsins may have therapeutic potential for attenuating such injuries.

MOLECULAR MEDICINE REPORTS (2022)

Review Cell Biology

Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury

Yang Liu et al.

Summary: Myocardial ischemia-reperfusion injury (MIRI) is the aggravation of myocardial injury caused by rapid recanalization of the ischemic myocardium. Pyroptosis, a type of inflammatory programmed death, plays a crucial role in MIRI development in combination with other mechanisms such as oxidative stress, calcium overload, necroptosis, and apoptosis. This review describes the mechanism of pyroptosis in MIRI and its relationship with other mechanisms, and highlights the involvement of non-coding RNAs and non-cardiomyocytes in regulating cardiomyocyte pyroptosis. Research progress on novel small molecule drugs, clinical drugs, and traditional Chinese medicine for regulating pyroptosis can greatly contribute to effective MIRI alleviation.
Article Biochemistry & Molecular Biology

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Carien Dekker et al.

Summary: The NLRP3 inflammasome responds to various pathogenic and sterile signals, producing interleukin-1 beta and interleukin-18. Understanding the structure of NLRP3 NACHT domain can provide insights into activation mechanisms and aid in the development of inhibitors for inflammatory diseases. Stabilizing the auto-inhibited form of the NACHT domain is an effective strategy to inhibit NLRP3 and could be beneficial in future therapeutic approaches.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Immunology

NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages

Yuhua Shi et al.

Summary: INF39 is a specific inhibitor for NLRP3 inflammasome activation, without affecting other inflammasomes. It exerts its anti-inflammatory effect by inhibiting the interaction of NEK7-NLRP3 and other downstream events.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases

Eleonora Mezzaroma et al.

Summary: NLRP3 inflammasome is a crucial player in cardiovascular diseases, regulating cell survival through the production of inflammatory mediators and being a target for inhibitors to block its harmful effects.

MOLECULES (2021)

Article Toxicology

Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model

Xiaofei Qiu et al.

Summary: Glibenclamide can protect dopaminergic neurons in a mouse PD model induced by combined exposures of paraquat and maneb by suppressing NLRP3 inflammasome activation, microglial M1 polarization, and oxidative stress.

TOXICOLOGY LETTERS (2021)

Review Endocrinology & Metabolism

Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway

Helene Duez et al.

Summary: The inflammasome, a master regulator of the innate immune system especially in macrophages, plays a key role in maintaining cellular health by cleaving pro-inflammatory cytokines in response to cytolytic pathogens or stress signals. Dysregulation of inflammasomes can lead to critical diseases, but they are tightly controlled by a two-step activation process involving transcription and complex formation. Recent studies have suggested nuclear receptors as additional regulators of this pathway, with potential benefits for inflammatory disease treatment.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Cell Biology

IP3R1 regulates Ca2+ transport and pyroptosis through the NLRP3/Caspase-1 pathway in myocardial ischemia/reperfusion injury

Guixi Mo et al.

Summary: This study revealed the important role of IP3R1 in myocardial ischemia/reperfusion by regulating Ca2+ levels, inflammation, and pyroptosis to improve injury. The binding of ERP44 to IP3R1 can inhibit Ca2+ overload, alleviating pyroptosis and myocardial ischemia/reperfusion injury.

CELL DEATH DISCOVERY (2021)

Review Biology

Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury

Wylly Ramses Garcia-Nino et al.

Summary: Ischemic preconditioning and postconditioning cardioprotective strategies target mitochondria to reduce I/R injury by activating protective signaling pathways and MQC processes, maintaining normal mitochondrial function and ensuring cardiomyocyte survival. MQC includes mitochondrial biogenesis, fission, fusion, mitophagy, and mitochondrial-controlled cell death. Modulation of MQC mechanisms and recognition of mitochondrial targets could offer a potential therapeutic approach for I/R-induced mitochondrial dysfunction.

LIFE-BASEL (2021)

Review Biochemistry & Molecular Biology

The role and transformative potential of IL-19 in atherosclerosis

Wujun Chen et al.

Summary: IL-19 plays a key role in reducing the development of atherosclerosis through various mechanisms. Low-dose recombinant IL-19 has shown significant anti-atherosclerotic effects in animal studies. The potential of IL-19 as a biomarker and therapeutic target for atherosclerosis warrants further investigation.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Review Cardiac & Cardiovascular Systems

The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart

Sergey V. Popov et al.

Summary: Inflammation plays a significant role in ischemia reperfusion injury, with pyroptosis potentially contributing considerably to infarction. Modulating inflammation through inhibition or activation of specific receptors can enhance cardiac tolerance to ischemia reperfusion injury.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)

Article Cell Biology

Mitochondrial regulation of ferroptosis

Boyi Gan

Summary: Mitochondria play crucial roles in driving and protecting cells in ferroptosis by actively regulating the process and providing defense mechanisms. A comprehensive understanding of mitochondrial functions holds important implications for unraveling mysteries in the field of ferroptosis.

JOURNAL OF CELL BIOLOGY (2021)

Review Cell Biology

Adding a Notch to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach

Luisa Marracino et al.

Summary: Dysregulation of the Notch pathway is implicated in cardiovascular diseases, and using microRNAs may offer a promising avenue for targeting Notch to treat common cardiovascular diseases.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Immunology

The cGAS-STING pathway as a therapeutic target in inflammatory diseases

Alexiane Decout et al.

Summary: The cGAS-STING signaling pathway plays a crucial role in inflammation in infection, cellular stress, and tissue damage settings. It has the ability to sense and regulate cellular responses to DNA and has the potential to be targeted in the treatment of various inflammatory diseases.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Cell Biology

Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury

Sean M. Davidson et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Myocardial ischaemia-reperfusion injury and cardioprotection in perspective

Gerd Heusch

NATURE REVIEWS CARDIOLOGY (2020)

Review Pharmacology & Pharmacy

Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors

Saveria Femmino et al.

VASCULAR PHARMACOLOGY (2020)

Review Cell Biology

NLRP3 inflammasome in endothelial dysfunction

Baochen Bai et al.

CELL DEATH & DISEASE (2020)

Article Clinical Neurology

Pro-inflammatory activation of microglia in the brain of patients with sepsis

T. Zrzavy et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)

Review Pharmacology & Pharmacy

MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies

Gulcin Tezcan et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Cardiac & Cardiovascular Systems

NLRP3 Inflammasome in Cardioprotective Signaling

Coert J. Zuurbier

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Coronary microvascular obstruction: the new frontier in cardioprotection

Gerd Heusch

BASIC RESEARCH IN CARDIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Innate immunity as a target for acute cardioprotection

Coert J. Zuurbier et al.

CARDIOVASCULAR RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury JACC Review Topic of the Week

Sean M. Davidson et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Medicine, Research & Experimental

The role of Ca2+ in acid-sensing ion channel 1a-mediated chondrocyte pyroptosis in rat adjuvant arthritis

Xiaoshan Wu et al.

LABORATORY INVESTIGATION (2019)

Review Dermatology

Colchicine: an ancient drug with novel applications

B. Dasgeb et al.

BRITISH JOURNAL OF DERMATOLOGY (2018)

Review Biochemistry & Molecular Biology

Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome

Raffaella Mastrocola et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

OLT1177, a ß-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Cardiac & Cardiovascular Systems

Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury

Stefano Toldo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

Review Biochemistry & Molecular Biology

Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target

Teresa Pasqua et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)

Article Biochemistry & Molecular Biology

Up-regulation of COX-2 and mPGES-1 by 27-hydroxycholesterol and 4-hydroxynonenal: A crucial role in atherosclerotic plaque instability

Simona Gargiulo et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Article Biochemistry & Molecular Biology

NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective

O. Sandanger et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Cardiac & Cardiovascular Systems

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

Benjamin W. Van Tassell et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)

Review Cell Biology

ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury

Letteria Minutoli et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Review Biochemistry & Molecular Biology

SOD2 and the Mitochondrial UPR: Partners Regulating Cellular Phenotypic Transitions

Chenxia He et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Immunology

Pyroptotic cell death defends against intracellular pathogens

Ine Jorgensen et al.

IMMUNOLOGICAL REVIEWS (2015)

Article Multidisciplinary Sciences

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Jianjin Shi et al.

NATURE (2015)

Article Biochemistry & Molecular Biology

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Rebecca C. Coll et al.

NATURE MEDICINE (2015)

Review Biochemistry & Molecular Biology

Reactive oxygen species and mitochondria: A nexus of cellular homeostasis

Joe Dan Dunn et al.

REDOX BIOLOGY (2015)

Review Biochemistry & Molecular Biology

Mechanisms and Functions of Inflammasomes

Mohamed Lamkanfi et al.

Article Pharmacology & Pharmacy

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose anti-interleukin-18 mAb GSK1070806 in healthy and obese subjects

Prafull Mistry et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)

Review Cardiac & Cardiovascular Systems

A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse

Carlo Marchetti et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)

Article Chemistry, Medicinal

Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis

Mattia Cocco et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Inflammatory caspases are innate immune receptors for intracellular LPS

Jianjin Shi et al.

NATURE (2014)

Review Biochemistry & Molecular Biology

Mitochondrial Pathways, Permeability Transition Pore, and Redox Signaling in Cardioprotection: Therapeutic Implications

Claudia Penna et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Article Cell Biology

Influence of Block of NF-Kappa B Signaling Pathway on Oxidative Stress in the Liver Homogenates

Paulina Kleniewska et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Review Biochemistry & Molecular Biology

Cardioprotective Pathways During Reperfusion: Focus on Redox Signaling and Other Modalities of Cell Signaling

Pasquale Pagliaro et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Multidisciplinary Sciences

Non-canonical inflammasome activation targets caspase-11

Nobuhiko Kayagaki et al.

NATURE (2011)

Review Biochemistry & Molecular Biology

Ischemia and reperfusion-from mechanism to translation

Holger K. Eltzschig et al.

NATURE MEDICINE (2011)

Article Biochemistry & Molecular Biology

Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury

Kaliyamurthi Venkatachalam et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Cell Biology

Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

Mohamed Lamkanfi et al.

JOURNAL OF CELL BIOLOGY (2009)

Review Cell Biology

MAM: more than just a housekeeper

Teruo Hayashi et al.

TRENDS IN CELL BIOLOGY (2009)

Article Multidisciplinary Sciences

Gout-associated uric acid crystals activate the NALP3 inflammasome

F Martinon et al.

NATURE (2006)